Neurological Genetic tests in Dubai & UAE

Compare available Neurological Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic test prices

Showing 31–45 of 49 matching tests.

Neurological Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4010 RAB7A Gene CMT2B Genetic Test This test detects pathogenic variants in the RAB7A gene associated with Charcot-Marie-Tooth disease type 2B.	Peripheral Whole Blood (EDTA) or DNA FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RAB7A gene", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about blood-thinning medications"] Indications ["Suspected Charcot-Marie-Tooth disease type 2B", "Family history of CMT2B", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81321-3 ICD-10: G60.0 Clinical summary This test detects pathogenic variants in the RAB7A gene associated with Charcot-Marie-Tooth disease type 2B.
TEST-5650 REEP1 Gene (SPG31) Genetic Test This diagnostic test evaluates the REEP1 gene for pathogenic variants associated with hereditary spastic paraplegia type 31 (SPG31).	Whole blood (2–3 mL EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the REEP1 gene", "Copy number variants (CNVs) in REEP1", "Sequence changes and small deletions/duplications in REEP1"] Parameters [{"name": "Technology", "reference_range": "Next-Generation Sequencing (NGS)"}, {"name": "Mutation Coverage", "reference_range": "All coding exons, splice sites, copy-number variants"}, {"name": "Clinical Sensitivity", "reference_range": ">99% for point mutations and indels"}, {"name": "Post-Test Counselling", "reference_range": "Included (DHA-licensed genetic counsellor)"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with unexplained progressive spasticity in the legs", "Individuals with a family history of hereditary spastic paraplegia", "Relatives of a known REEP1 mutation carrier", "At-risk couples undergoing preconception genetic screening"] Measurement technique Confirm with laboratory Codes LOINC: 81262-2 ICD-10: G11.4 Clinical summary This diagnostic test evaluates the REEP1 gene for pathogenic variants associated with hereditary spastic paraplegia type 31 (SPG31).
TEST-3830 RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test This test identifies pathogenic variants in the RNF170 gene associated with Autosomal Dominant Sensory Ataxia Type 1.	Peripheral Whole Blood or FTA Card Sample	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RNF170 gene", "Autosomal dominant mutations"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless instructed otherwise"] Indications ["Suspected Sensory Ataxia Type 1", "Differential diagnosis of hereditary ataxia", "Family screening for RNF170 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 94233-3 ICD-10: G60.0 Clinical summary This test identifies pathogenic variants in the RNF170 gene associated with Autosomal Dominant Sensory Ataxia Type 1.
TEST-4460 SCN10A Gene Episodic Pain Syndrome Type 2, Familial Test This test evaluates the SCN10A gene for pathogenic variants associated with familial episodic pain syndrome type 2 (FEPS2). It uses next-generation sequencing (NGS) to analyze the...	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN10A gene sequence", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number variations"] Parameters [] Preparation ["No fasting required", "Clinical pain history needed", "Attend a 20-minute genetic counselling session before the blood draw"] Indications ["Suspected familial episodic pain syndrome type 2 (FEPS2)", "Recurrent episodes of severe pain with unclear etiology"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G90.8, Z14.8, R52 Clinical summary This test evaluates the SCN10A gene for pathogenic variants associated with familial episodic pain syndrome type 2 (FEPS2). It uses next-generation sequencing (NGS) to analyze the entire coding region.
TEST-4395 SCN11A Gene Episodic Pain Syndrome Type 3 Familial Genetic Test This test identifies pathogenic variants in the SCN11A gene associated with familial episodic pain syndrome type 3.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks (expedited 2‑week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN11A gene", "Coding region, deep intronic, and splice-site regions of SCN11A"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any ongoing therapeutic anticoagulation"] Indications ["Suspected familial episodic pain syndrome type 3", "Diagnosis of paroxysmal extreme pain disorder", "Family risk assessment for SCN11A-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81223-8 ICD-10: G90.89, Z15.89, Z82.2 Clinical summary This test identifies pathogenic variants in the SCN11A gene associated with familial episodic pain syndrome type 3.
TEST-4282 SCN1A Gene (Early Infantile Epileptic Encephalopathy Type 6) Genetic Test This test evaluates the SCN1A gene for pathogenic variants associated with early infantile epileptic encephalopathy type 6 (Dravet syndrome).	Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks (STAT option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN1A gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected Dravet syndrome", "Early infantile epileptic encephalopathy", "Unexplained seizures in infancy"] Measurement technique Confirm with laboratory Codes LOINC: 21680-2 ICD-10: G40.3 Clinical summary This test evaluates the SCN1A gene for pathogenic variants associated with early infantile epileptic encephalopathy type 6 (Dravet syndrome).
TEST-4477 SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test This test evaluates the SCN1A gene for pathogenic variants associated with Familial Hemiplegic Migraine Type 3.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN1A gene sequence", "Pathogenic variants in SCN1A coding region and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected diagnosis of Familial Hemiplegic Migraine Type 3", "Family history of FHM3", "Genetic counselling for migraine disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G43.409 Clinical summary This test evaluates the SCN1A gene for pathogenic variants associated with Familial Hemiplegic Migraine Type 3.
TEST-5521 SCN4A Gene Potassium-Aggravated Myotonia Genetic Test This test identifies mutations in the SCN4A gene associated with potassium-aggravated myotonia.	Peripheral whole blood	3–4 weeks (standard) / 2 weeks (expedited)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN4A gene sequence", "Copy Number Variations (CNV) in SCN4A"] Parameters [] Preparation ["Avoid potassium-rich foods or supplements 24 hours prior if instructed by the referring doctor", "A mandatory pre-test genetic counseling session is required"] Indications ["Suspected potassium-aggravated myotonia", "Family history of myotonic disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81306-2 ICD-10: G71.19 Clinical summary This test identifies mutations in the SCN4A gene associated with potassium-aggravated myotonia.
TEST-3716 SLC12A6 Genetic Test This test evaluates the entire SLC12A6 gene for pathogenic variants associated with Andermann syndrome.	Peripheral whole blood, extracted DNA, or dried blood spot	25–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC12A6 gene", "Copy Number Variants (CNVs) within SLC12A6"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Patients presenting with partial or complete agenesis of the corpus callosum on neuroimaging", "Patients with progressive axonal neuropathy", "Patients with developmental delay", "Family history suggestive of autosomal recessive Andermann syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 8251-1 ICD-10: Q04.0, G60.0 Clinical summary This test evaluates the entire SLC12A6 gene for pathogenic variants associated with Andermann syndrome.
TEST-4317 SLC25A22 Gene Early Infantile Epileptic Encephalopathy Type 3 Genetic Test This genetic test detects pathogenic variants in the SLC25A22 gene associated with Early Infantile Epileptic Encephalopathy Type 3.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A22 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Family pedigree chart required"] Indications ["Infants with suspected Early Infantile Epileptic Encephalopathy Type 3", "Neonatal-onset epilepsy with developmental regression"] Measurement technique Confirm with laboratory Codes LOINC: 21656-5 ICD-10: G40.5 Clinical summary This genetic test detects pathogenic variants in the SLC25A22 gene associated with Early Infantile Epileptic Encephalopathy Type 3.
TEST-3767 SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 (ALS1) Genetic Test This genetic test evaluates the SOD1 gene for variants associated with Amyotrophic Lateral Sclerosis Type 1 (ALS1).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOD1 gene variants (SNVs, indels)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for SNVs & small indels"}] Preparation ["No fasting required", "No medication changes required", "Mandatory pre-test genetic counselling session"] Indications ["Suspected familial ALS1", "Confirmation of clinical diagnosis", "Family member screening", "Clinical trial enrollment"] Measurement technique Confirm with laboratory Codes LOINC: 69548-9 ICD-10: G12.21, Z15.09, Z13.858 Clinical summary This genetic test evaluates the SOD1 gene for variants associated with Amyotrophic Lateral Sclerosis Type 1 (ALS1).
TEST-4235 SPR Gene Dystonia (DOPA‑Responsive, Autosomal Recessive) Genetic Test (NGS) This test identifies pathogenic variants in the SPR gene associated with DOPA-responsive dystonia, an autosomal recessive disorder.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPR gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory before sampling"] Indications ["Suspected DOPA-responsive dystonia", "Family history of DOPA-responsive dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 94309-9 ICD-10: G24.8, Z14.8, Z36.89 Clinical summary This test identifies pathogenic variants in the SPR gene associated with DOPA-responsive dystonia, an autosomal recessive disorder.
TEST-4148 TARDBP Gene Frontotemporal Dementia Genetic Test This genetic test evaluates the TARDBP gene for pathogenic variants associated with frontotemporal dementia and amyotrophic lateral sclerosis.	Whole Blood (venous), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TARDBP gene", "Single nucleotide variants", "Small insertions and deletions"] Parameters [] Preparation ["Pre-test genetic counseling session required.", "Detailed pedigree chart construction."] Indications ["Suspected frontotemporal dementia (FTD)", "Suspected amyotrophic lateral sclerosis (ALS)", "Family history of FTD or ALS", "Clarification of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92811-1 ICD-10: G31.09 Clinical summary This genetic test evaluates the TARDBP gene for pathogenic variants associated with frontotemporal dementia and amyotrophic lateral sclerosis.
TEST-4236 TBC1D24 Gene (EIEE16) Next-Generation Sequencing DNA Test This test identifies pathogenic variants in the TBC1D24 gene associated with Early Infantile Epileptic Encephalopathy Type 16 (EIEE16), a severe neonatal seizure disorder.	Peripheral whole blood (EDTA tube) or FTA dried blood spot card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TBC1D24 gene coding regions and intron-exon boundaries"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of Early Infantile Epileptic Encephalopathy Type 16 (EIEE16)", "Recurrence risk counseling for families with EIEE16"] Measurement technique Confirm with laboratory Codes LOINC: 21649-1 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the TBC1D24 gene associated with Early Infantile Epileptic Encephalopathy Type 16 (EIEE16), a severe neonatal seizure disorder.
TEST-5672 TECPR2 Gene SPG49 Genetic Test This test detects pathogenic variants in the TECPR2 gene to diagnose autosomal recessive spastic paraplegia type 49 (SPG49).	Whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TECPR2 gene", "Copy-number variants (CNVs) in the TECPR2 gene"] Parameters [] Preparation ["Provide comprehensive neurological history", "Mandatory pre-test genetic counseling", "Signed informed consent"] Indications ["Diagnosis of suspected autosomal recessive spastic paraplegia type 49 (SPG49)", "Family counseling for TECPR2-associated conditions", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: G11.4, Z13.7, Z14.8 Clinical summary This test detects pathogenic variants in the TECPR2 gene to diagnose autosomal recessive spastic paraplegia type 49 (SPG49).

Category overview

Neurological Genetic: overview

Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurological Genetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurological genetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.